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Abstract 
AIM: To investigate the relationship between the polymorphism of related gene loci of miRNAs regulated 
fibrinopeptide A and schizophrenia. Lay the foundation for the aetiology of schizophrenia. 
METHODS: Adapt to the phase match of sex and age case-control study, a total of 513 Chinese Han patients 
with schizophrenia were selected as the case group, 513 normal healthy persons as a control group. Obtaining 
SNPs information of the FGA gene by querying the dbSNP database, and reference HapMap database included 
SNPs site frequency information for screening. The frequency distributions of SNPs were genotyped by iMLDR® 
SNP detection technology. Two SNPs (pre-hsa-miR-605rs2043556 T>C, pre-hsa-miR-499a/pre-hsa-miR-
499brs4909237 T < C) were analyzed to demonstrate their association with susceptibility to schizophrenia. 
RESULTS: There were no significant differences between patients and controls in genotype and allele distribution 
of SNPs（rs2043556 and rs4909237）in the precursor region of hsa-miR-605 and pre-hsa-miR-499a/pre-hsa-
miR-499b. Their gene-gene interaction, which suggests that the polymorphisms of miRNA genes might not 
contribute to schizophrenia susceptibility in the Han Chinese population. 
CONCLUSION: No significant difference existed between schizophrenic patients and controls in SNP (rs2043556 
and rs4909237) in the precursor region of hsa-miR-605 and pre-hsa-miR-499a/pre-hsa-miR-499b. There may not 
regulate FGA gene expression. Thus, hsa-miR-605 and pre-hsa-miR-499a/pre-hsa-miR-499b may not influence 
the risks of schizophrenia. 
 
 
 
 
Introduction 
 
Schizophrenia is a complex mental illness that 
often comes from big hurt emotional [1]. The 
behaviour of the main performance by Psychological 
illusion, altered cognition, delusions, behavioural 
disorders and emotionally sensitive [2]. Seriously 
affect people's health and quality of life. Epidemiologic 
studies show that schizophrenia patients are up to 
1%. However, the pathogenesis of schizophrenia is 
unclear. Which usually causes diagnosis errors. 
Medical diagnosis is more and more 
development. However, the diagnosis of 
schizophrenia still can only rely on the patient's 
behaviour to determine because of the pathogenesis 
and aetiology of schizophrenia remain unclear. No 
laboratory diagnostics is available. For the diagnosis 
of schizophrenia, we need an accurate professional 
diagnosis or a diagnostic tool. So it is important that 
the marker should play a significant role in the 
diagnosis of schizophrenia [3]. 
Fibrinopeptide A (FPA) is a product of 
proteolysis by thrombin of fibrinogen [4]. Now some 
previous studies using the mass spectrum analysis to 
prove that fibrinopeptide A (FPA) could be a potential 
biomarker for schizophrenia diagnosis [5]. MicroRNAs 
(miRNAs) are single-stranded RNA molecules, 
consisting of 21-23 nucleotides, which has the 
function of regulation [6]. The highly conservative 
endogenous non-coding RNA has extensive biological 
functions. According to some studies, most miRNAs 
are expressed in neurons and performance obvious 
patterns in the central nervous system. This means 
that miRNAs are the importance of brain development 
and function [7]. MicroRNAs such as most species of 
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a miRNA have accurately exact ends, behave like 
traditional polymeric products of gene activity, 
although there is a little variation [8]. Regulation of 
miRNA biogenesis is an important issue but no more 
extensively studied. However, there has an interesting 
tendency emerging [9]. An amazing much of miRNA 
genes are formed under the control of the very targets 
that they regulate [8]. 
Now this study based on our previous work, 
as the schizophrenia research object in the Chinese 
Han population. By adopting the method of a case-
control study, using bioinformatics technology, from 
the level of the miRNA gene sequence, analysing the 
relationship between the regulating FGA protein of 
miRNAs and schizophrenia, provide important clues 
about the molecular mechanisms of schizophrenia 
occurs. 
 
 
Material and Methods 
 
Study of Population. Our study included 513 
schizophrenia patients that come from 2006 to 2010 
years in the sixth hospital of Changchun and 
encephalopathy hospital of Jilin province. Among 
patients includes 273 cases of male and 240 cases of 
women (mean age = 32.23 ± 11.16 years; 53.2% 
males) that all Han people from in Northeast China. 
Each patient was diagnosed by two or more 
physicians according to the criteria of the international 
classification of diseases from the tenth version of 
schizophrenia (ICD-10). At the same time, according 
to the Chinese classification and diagnostic criteria of 
mental disorders Third Edition (CCMD-3). Healthy 
people from the 2008 Changchun subhealth survey. 
Inclusion criteria were not previously diagnosed with 
chronic disease and A person without the obvious 
organic disease. Eliminate gestation or lactation 
women and schizophrenia. A total of 513 control 
people, includes 245 males and 268 females (mean 
age = 31.54 ± 9.35 years; 47.76% males), all blood-
supply person sign agreement. Venous blood 5 mL, 
frozen in the refrigerator at -20°C, use of genomic 
DNA extraction. 
Prediction of miRNA and selection of 
polymorphic loci. First of all, It was confirmed that the 
miRNA regulated of FGA gene by using mirtarbase 
online software query and by experiment; predicted 
the miRNA by using microcosm, Target, mirSVR and 
TargetS online software; Then miRNA was BLAST 
and BLAST-SNP in NCBI's dbSNP database 
(Build147); evaluated the effect that SNP influenced 
the interaction of the miRNA- target gene by using 
energy value (△G) of RNAhybrid online software; 
Finally, the frequency of these SNP in Chinese Han 
population was examined in the SNP database. 
Screening criteria: MAF > 10%. 
DNA Extraction and SNP Genotyping. Extract 
of genomic DNA from peripheral blood leukocytes and 
use micropore nuclein analyser（American Bio Tex）
to identify the quality of genomic DNA extracted. 
Identification standard: the concentration of DNA > 10 
ng/ L. For compliance with the standard DNA was 
multiplex SNP typing by using of imLDRTM. (IMLDR 
technology based on the traditional ligase reaction 
was improved of possessing proprietary intellectual 
property rights of multiple SNP typing technologies, 
compared with the traditional ligase reaction 
technique, IMLDR improves the accuracy and the 
success rate of typing. After repeated experiments 
and preliminary validation of a double-blind sample, 
the accuracy of the data is more than 98%, after 
sequencing and the Snapshot. Experimental design 
and operating instructions: 
1. The section of the target SNP site was 
used multiple PCR reaction in a single system and 
amplification. 
2. Amplified products were used follow-up 
ligase reaction templet after purification by an 
exonuclease and ExoI/SAP. 
3. In a connection reaction, each site contains 
two 5' allele-specific probes (at the end of 3, there are 
two allele-specific bases or sequences, in terms of 
inserting loss polymorphism) and followed a 
fluorescent labelled specific probes for 3 'terminal 
sites. The products were identified by ABI3730XL 
capillary electrophoresis. The original data file was 
analysed by GeneMapper4.1 software (Applied 
Biosystems). 
We selected two tagSNPs located in the 
fibrinogen alpha chain gene (FGA) included 
rs2043556, rs4909237. The information of DNA 
primers was shown in Table 1. 
Table 1: Primers for polymerase chain reaction 
SNPs Primer sequence (5'-3') 
rs2043556 F：5'-CCCGCCTCTTTTTGCTCATTCT -3' , 
 R：5'-TTGCAGAGCAGTTACGCCACAT -3' 
rs4909237 F：5'- AGACACACCACGGCACACTTCA -3' , 
 R：5'- GGCCACATTCTCTCTGCCATGT-3' 
 
Statistical Analysis. Data processing used 
SPSS 13.0 software. Hardy-Weinberg (H-W), genetic 
equilibrium test, was performed by goodness of Chi-
Square fit test; the measurement data is expressed as 
a s, the count data is expressed as the number of 
cases and the percentage (%); comparison of 
measurement data using independent sample t-test; 
The allele frequency difference of genotype and 
compared using 
2
 test; Gene-gene interaction of 
miRNA was analysed by Logistic regression; Genetic 
model analysis was performed using SNPs that online 
genetic analysis software. The statistical significance 
level was set at 0.05, and all statistical tests were two-
sided. 
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Results 
 
1. Demographic Characteristics: 1026 
schizophrenia parents and control group were 
included in this study; there were no significant 
diﬀerences were found between patients and healthy 
controls in sex (   = 3.057, P = 0.080). 
2. Hard-Weinberg equilibrium: No deviation 
from HWE in schizophrenia and control groups in the 
two SNPs (P > 0.05). The object of the sample study 
had a good group representative that from a random 
mating large sample, no migration and cousin 
marriage. 
3. The Allele and Genotype Analysis: Table 2 
displays genotype distributions and allele frequencies 
of SNPs in schizophrenic patients and healthy 
controls. There were no significant diﬀerence (P > 
0.05) in genotypic and allelic frequency in the two 
SNPs (rs2043556 and rs 4909237). 
Table 2: Comparison of allele frequencies and genotype 
distributions between case and control group 
SNP Group Genotypic 
frequency 
  Allelic frequency   
  C/C C/T T/T    P C T    P 
rs2043556 Case 41 191 278 0.562 0.755 273 747 < 0.001 0.994 
 control 36 199 271   271 741   
rs 4909237 case 273 202 38 0.840 0.657 748 278 0.810 0.368 
 control 283 194 32   760 258   
 
4. Genetic model analysis: According to 
SNPstats online software, analysis polymorphism of 
two SNPs with the correlation of schizophrenia in 
codominant, dominant, recessive overdominant and 
log-additive, at the same time adjusting age and sex, 
there were not significant statistical with the 
correlation of schizophrenia(P > 0.05). The optimal 
genetic model was overdominant (ORC/T-C/C vs C/T = 
1.10, 95%CI 0.85-1.42, P = 0.47, AIC = 1411.2) at 
rs2043556. The optimal genetic model of rs4909237 
was dominant (ORC/T-T/T vs C/C=0.91, 95%CI 0.74-1.23, 
P = 0.45, AIC = 1419.6). 
Table 3: Comparison of genetic models between case and 
control group 
locus Genetic model genotype case(%） control（%） OR（95%CI） P AIC 
rs2043556 
 
 
 
 
 
Codominant T/T 
C/T 
C/C 
278（54.5） 
191（37.5） 
41（8.1） 
271（53.6） 
199（39.3） 
36（7.1） 
1.00 
1.08（0.84-1.41） 
0.89（0.55-1.44） 
 
 
0.69 
 
 
1413 
Dominant T/T 
C/T-C/C 
278（54.5） 
232（45.5） 
271（53.6） 
235（46.4） 
1.00 
1.05（0.82-1.34） 
 
0.7 
 
1411.6 
Recessive T/T-C/T 
C/C 
469（92） 
41（8） 
470（92.9） 
36（7.1） 
1.00 
0.86 (0.54-1.38) 
 
0.54 
 
1411.4 
Overdominant T/T-C/C 
C/T 
319(62.5) 
191(37.5) 
307 (60.7) 
198 (39.3) 
1.00 
1.10 (0.85-1.42) 
 
0.47 
 
1411.2 
rs4909237 
 
 
Codominant T/T 
C/T 
C/C 
38（7.4） 
202（39.4） 
273（53.2） 
32（6.3） 
194（38.1） 
283（55.6） 
0.80(0.48-1.31) 
0.93（0.72-1.20） 
1 
 
 
0.63 
 
 
1421.3 
Dominant C/C 
C/T-T/T 
273 （ 53.2 ）
240（46.8） 
283（55.6） 
226（44.4） 
1.00 
0.91（0.71-1.16） 
 
0.45 
 
1419.6 
Recessive C/C-C/T 
T/T 
475（92.6） 
38（7.4） 
477（93.7） 
32（6.3） 
1.00 
0.82 (0.50-1.34) 
 
0.43 
 
1419.6 
Overdominant C/C-T/T 
C/T 
311(60.6) 
202(39.4) 
315 (61.9) 
194 (38.1) 
1.00 
0.95 (0.74-1.23) 
 
0.72 
 
1420.1 
 
5. Gene-gene interaction: According to 
statistical analysis, there were no significant 
diﬀerences were found between gene-gene 
interaction. 
Table 4: Gene-gene interactions on schizophrenia risks 
rs2043556 rs4909237 Wals P OR 95%CI 
     Lower Upper 
C/T C/T 0.000 0.999 2.671 0.000  
C/T C/C 0.556 0.456 0.668 0.231 1.931 
C/C C/T 0.000 0.999 5.058 0.000  
C/C C/C 0.015 0.903 0.883 0.120 6.497 
T/T C/T 0.000 0.999 4.847 0.000  
 
 
 
Discussion 
 
Our study first presents the correlation 
between the polymorphism of miRNAs locus regulated 
fibrinogen A and schizophrenia in the Han Chinese 
population. We found in the SNPs (rs2043556 and 
rs4909237): there were no significant diﬀerence (P > 
0.05) in genotypic and allelic frequency; there were no 
significant diﬀerence (P > 0.05) in Genetic mode; 
In recent years, our group concluded that FPA 
(Fibrinogen A) has the potential to be a biomarker 
about the diagnosis of schizophrenia according to 
comparing of serum protein profiling for first-episode 
schizophrenia, this protein could also help to 
determine schizophrenia pathogenesis [3]. Some 
study found the Fibrinogen in the blood of 
schizophrenic patients was significantly higher than 
that of healthy people [10]. Fibrinogen could be a 
blood index for the diagnosis of schizophrenia. Our 
group also studied the association between the 
fibrinogen alpha chain gene polymorphisms and 
schizophrenia [11]. Another study also further to 
demonstrate that relationship between polymorphisms 
in the fibrinogen alpha chain Gene(FGA) and 
Schizophrenia [5]. 
Schizophrenia is the complex multifactorial 
genetic diseases; the author found miRNA regulate 
gene expression may play a role in brain development 
[12]. Some studies displayed miRNA-SNP could 
impact the function of miRNA; it is a newly discovered 
polymorphism in the human genome. MicroRNA gene 
polymorphism as a new way of thinking for searching 
potential regulation of mental disorders and to provide 
a new reference for the pathogenic mechanism of 
related diseases. Thibaut et al found a new potentially 
functional variant ss178077483 located in the pre-mir-
30e strongly associated with schizophrenia (allelic P = 
0.00017; genotypic P = 0.00015) [13]. Hansen et al. 
confirmed rs17578796 in mir-206 and rs1700 in mir-
198 were associated with schizophrenia in a 
Scandinavian population [14]. Jensen et al studies 
showed that miR-330-3p(rs41305272) associated with 
severe depression in some Americans (OR = 1.95, P 
= 0.007) [15]. There are strict rules of recognition 
between miRNAs and target genes, therefore, the 
SNPs (miRNA-SNPs) located in the miRNA gene 
region includes the miRNAs gene, and the target site 
of SNP could decorate miRNAs to regulate and 
control phenotypic type and disease susceptibility 
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[16]. At the same time, it has been shown that there is 
a correlation between SNPs located in the miRNAs 
target gene locus and different diseases [17], 
especially in the field of schizophrenia [13]. 
MiR-SNPs may use new or alter function to 
contribute to the evolution of miRNAs, also may show 
the generation of clustered miRNAs for the 
mechanism, family members of miRNAs during 
evolution, or miRNA homologs [11]. If we figure out 
the mechanisms clear, the genetic factors of 
schizophrenia will soon be resolved. 
In conclusion, our study had some limitations. 
First, the low sample size may lead to no significant 
diﬀerence; Second, we used the imLDRTM to 
genotyping; this technology improves the traditional 
LDRSNP classification technology. We didn't have all 
the research samples to genotyping; Last, the sample 
size large differences in three preliminary studies, 
very few data can be matched, low accuracy of union 
analysis, our study did not integrate the data. 
Although we did not find the relationship between 
SNPs (rs2043556 and rs4909237) and schizophrenia, 
we will be further to find more SNPs and study them 
associated with schizophrenia. 
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